英唐智控(300131.SZ):“深圳市英唐智能控制股份有限公司MEMS微振鏡研發及產業化項目”擬延期至2026年9月
格隆匯2月25日丨英唐智控(300131.SZ)公佈,公司於2025年2月24日召開了第六屆董事會第七次會議、第六屆監事會第五次會議,審議通過了《關於募集資金投資項目延期的議案》,同意公司結合募投項目實施過程中的實際進展情況,將募集資金投資項目“深圳市英唐智能控制股份有限公司MEMS微振鏡研發及產業化項目”達到預定可使用狀態的時間延期至2026年9月。本次募投項目延期事項在董事會審批權限範圍內,無需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.